Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy of CP-COV03 in Dengue Patients (Part 1) / Dengue and Dengue-like Illness Patients (Part 2)

NCT07576868 is registered in ClinicalTrials.gov with Hyundai Bioscience Co., Ltd. as lead sponsor.

NCT NCT07576868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy of CP-COV03 in Dengue Patients (Part 1) / Dengue and Dengue-like Illness Patients (Part 2)
Lead sponsor
Hyundai Bioscience Co., Ltd.
Phase
Phase 2/3
Overall status
Recruiting
Start date
April 9, 2026
Completion date
May 31, 2027
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dengue